These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 15868899

  • 1. A potential role for vascular endothelial growth factor-D as an autocrine growth factor for human breast carcinoma cells.
    Akahane M, Akahane T, Shah A, Okajima E, Thorgeirsson UP.
    Anticancer Res; 2005; 25(2A):701-7. PubMed ID: 15868899
    [Abstract] [Full Text] [Related]

  • 2. Vascular endothelial growth factor C stimulates progression of human gastric cancer via both autocrine and paracrine mechanisms.
    Kodama M, Kitadai Y, Tanaka M, Kuwai T, Tanaka S, Oue N, Yasui W, Chayama K.
    Clin Cancer Res; 2008 Nov 15; 14(22):7205-14. PubMed ID: 19010837
    [Abstract] [Full Text] [Related]

  • 3. Autocrine vascular endothelial growth factor signalling in breast cancer. Evidence from cell lines and primary breast cancer cultures in vitro.
    Weigand M, Hantel P, Kreienberg R, Waltenberger J.
    Angiogenesis; 2005 Nov 15; 8(3):197-204. PubMed ID: 16328160
    [Abstract] [Full Text] [Related]

  • 4. HSulf-1 inhibits angiogenesis and tumorigenesis in vivo.
    Narita K, Staub J, Chien J, Meyer K, Bauer M, Friedl A, Ramakrishnan S, Shridhar V.
    Cancer Res; 2006 Jun 15; 66(12):6025-32. PubMed ID: 16778174
    [Abstract] [Full Text] [Related]

  • 5. Hypoxia-induced epithelial VEGF-C/VEGFR-3 upregulation in carcinoma cell lines.
    Simiantonaki N, Jayasinghe C, Michel-Schmidt R, Peters K, Hermanns MI, Kirkpatrick CJ.
    Int J Oncol; 2008 Mar 15; 32(3):585-92. PubMed ID: 18292935
    [Abstract] [Full Text] [Related]

  • 6. Interleukin 7 upregulates vascular endothelial growth factor D in breast cancer cells and induces lymphangiogenesis in vivo.
    Al-Rawi MA, Watkins G, Mansel RE, Jiang WG.
    Br J Surg; 2005 Mar 15; 92(3):305-10. PubMed ID: 15672426
    [Abstract] [Full Text] [Related]

  • 7. ErbB2 increases vascular endothelial growth factor protein synthesis via activation of mammalian target of rapamycin/p70S6K leading to increased angiogenesis and spontaneous metastasis of human breast cancer cells.
    Klos KS, Wyszomierski SL, Sun M, Tan M, Zhou X, Li P, Yang W, Yin G, Hittelman WN, Yu D.
    Cancer Res; 2006 Feb 15; 66(4):2028-37. PubMed ID: 16489002
    [Abstract] [Full Text] [Related]

  • 8. Antisense to cyclin D1 inhibits vascular endothelial growth factor-stimulated growth of vascular endothelial cells: implication of tumor vascularization.
    Yasui M, Yamamoto H, Ngan CY, Damdinsuren B, Sugita Y, Fukunaga H, Gu J, Maeda M, Takemasa I, Ikeda M, Fujio Y, Sekimoto M, Matsuura N, Weinstein IB, Monden M.
    Clin Cancer Res; 2006 Aug 01; 12(15):4720-9. PubMed ID: 16899623
    [Abstract] [Full Text] [Related]

  • 9. Lentivirus-mediated small interfering RNA targeting VEGF-C inhibited tumor lymphangiogenesis and growth in breast carcinoma.
    Guo B, Zhang Y, Luo G, Li L, Zhang J.
    Anat Rec (Hoboken); 2009 May 01; 292(5):633-9. PubMed ID: 19382240
    [Abstract] [Full Text] [Related]

  • 10. Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation.
    Zetser A, Bashenko Y, Edovitsky E, Levy-Adam F, Vlodavsky I, Ilan N.
    Cancer Res; 2006 Feb 01; 66(3):1455-63. PubMed ID: 16452201
    [Abstract] [Full Text] [Related]

  • 11. Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases.
    Tang Y, Nakada MT, Kesavan P, McCabe F, Millar H, Rafferty P, Bugelski P, Yan L.
    Cancer Res; 2005 Apr 15; 65(8):3193-9. PubMed ID: 15833850
    [Abstract] [Full Text] [Related]

  • 12. Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth.
    Karpanen T, Egeblad M, Karkkainen MJ, Kubo H, Ylä-Herttuala S, Jäättelä M, Alitalo K.
    Cancer Res; 2001 Mar 01; 61(5):1786-90. PubMed ID: 11280723
    [Abstract] [Full Text] [Related]

  • 13. Overexpression of macrophage migration inhibitory factor induces angiogenesis in human breast cancer.
    Xu X, Wang B, Ye C, Yao C, Lin Y, Huang X, Zhang Y, Wang S.
    Cancer Lett; 2008 Mar 18; 261(2):147-57. PubMed ID: 18171602
    [Abstract] [Full Text] [Related]

  • 14. Overexpression of cyclin DI contributes to malignant properties of esophageal tumor cells by increasing VEGF production and decreasing Fas expression.
    Shintani M, Okazaki A, Masuda T, Kawada M, Ishizuka M, Doki Y, Weinstein IB, Imoto M.
    Anticancer Res; 2002 Mar 18; 22(2A):639-47. PubMed ID: 12014632
    [Abstract] [Full Text] [Related]

  • 15. [Effects of VEGF-A/VEGF-C antisense oligodeoxynucleotide on angiogenesis, lymphangiogenesis, and tumor growth of breast cancer].
    Chen JS, Zhang YJ, Hu SE, Zhang HQ.
    Ai Zheng; 2007 Sep 18; 26(9):972-6. PubMed ID: 17927855
    [Abstract] [Full Text] [Related]

  • 16. Clinicopathological and prognostic significance of vascular endothelial growth factors (VEGF)-C and -D and VEGF receptor 3 in invasive breast carcinoma.
    Mylona E, Alexandrou P, Mpakali A, Giannopoulou I, Liapis G, Markaki S, Keramopoulos A, Nakopoulou L.
    Eur J Surg Oncol; 2007 Apr 18; 33(3):294-300. PubMed ID: 17129704
    [Abstract] [Full Text] [Related]

  • 17. The effect of versican G3 domain on local breast cancer invasiveness and bony metastasis.
    Yee AJ, Akens M, Yang BL, Finkelstein J, Zheng PS, Deng Z, Yang B.
    Breast Cancer Res; 2007 Apr 18; 9(4):R47. PubMed ID: 17662123
    [Abstract] [Full Text] [Related]

  • 18. Overexpression of estrogen receptor-alpha in the endometrial carcinoma cell line Ishikawa: inhibition of growth and angiogenic factors.
    Ali SH, O'Donnell AL, Mohamed S, Mousa S, Dandona P.
    Gynecol Oncol; 2004 Dec 18; 95(3):637-45. PubMed ID: 15581976
    [Abstract] [Full Text] [Related]

  • 19. Repression of vascular endothelial growth factor expression by the zinc finger transcription factor ZNF24.
    Harper J, Yan L, Loureiro RM, Wu I, Fang J, D'Amore PA, Moses MA.
    Cancer Res; 2007 Sep 15; 67(18):8736-41. PubMed ID: 17875714
    [Abstract] [Full Text] [Related]

  • 20. Vesnarinone inhibits angiogenesis and tumorigenicity of human oral squamous cell carcinoma cells by suppressing the expression of vascular endothelial growth factor and interleukin-8.
    Harada K, Supriatno, Yoshida H, Sato M.
    Int J Oncol; 2005 Dec 15; 27(6):1489-97. PubMed ID: 16273203
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.